Melanotan II and Tanning: Risks, Approval Status and Safer Sun Protection
What Bali residents and visitors should know about Melanotan II tanning injections and sprays, including approval, dosing inconsistency and sun-risk myths.
In brief
Melanotan II is an unapproved tanning peptide promoted as injections and nasal sprays. Regulators warn about unknown quality, inconsistent content and adverse effects. It does not make ultraviolet exposure safe or replace sun protection. In August 2026, Australia's TGA reported major quantity inconsistencies in seized Melanotan II products and reiterated that none were approved there.
What is established—and what is not
- Approval
- No TGA-approved Melanotan II product; verify BPOM separately
- Quality signal
- TGA found materially inconsistent quantities in seized products
- Sun exposure
- A tan does not eliminate ultraviolet damage
- Key uncertainty
- Unregulated injections and sprays may not match their labels
Five points to keep
- Melanotan II is not a sunscreen and does not make intentional UV exposure safe.
- Unapproved online products can vary in identity and quantity.
- Injection and nasal routes create different exposure and quality concerns.
- New or changing pigmented lesions require professional assessment.
- Use proven sun-protection measures in Bali's high-UV environment.
Why tanning peptides are attractive in Bali
Bali's outdoor lifestyle and strong ultraviolet exposure make fast-tanning claims easy to market. Melanotan II is promoted as a way to darken skin with less sun, often through self-injection or nasal products.
That framing can hide two distinct risks: the unapproved product itself and the continuing harm from ultraviolet exposure.
What regulators have found
Australia's TGA reported in August 2026 that seized Melanotan II products contained materially inconsistent quantities and that no Melanotan II product was approved in Australia for supply. FDA's peptide safety information also identifies Melanotan II among substances of concern.
These are foreign regulatory findings, not a substitute for checking BPOM status in Indonesia. They demonstrate why online availability and label claims are weak evidence of quality.
A tan is not reliable protection
Darkening of the skin does not cancel DNA damage from ultraviolet radiation. People using a tanning product may feel falsely protected and stay in the sun longer.
Sun protection still relies on shade, clothing, appropriate sunscreen and timing choices. A dermatologist should assess concerning or changing lesions.
Route and product-quality problems
Injectable products require reliable identity, concentration, sterility and handling. Nasal products require their own formulation and absorption evidence. Neither route becomes safe because the product is labelled “research use only.”
Adverse effects and unknown contaminants may be difficult to attribute when the actual contents are uncertain.
A safer decision pathway
Avoid unapproved tanning injections and sprays. Check any therapeutic claim with BPOM, use established sun protection, and seek medical advice for adverse symptoms or skin changes. Laboratory research should remain laboratory research.
Common questions, careful answers
Is Melanotan II approved for tanning?
Australia's TGA states that no Melanotan II product is approved there. Verify current Indonesian status through BPOM rather than relying on a seller.
Does Melanotan II protect against sun damage?
It should not be treated as sun protection. Ultraviolet damage can still occur.
Are nasal tanning sprays safer than injections?
A different route does not establish safety. Unapproved nasal products can still have quality, dosing and systemic-exposure risks.
Evidence, standards and regulatory sources
- Melanotan II products found to be inconsistently dosed ↗Australian Therapeutic Goods Administration
- FDA peptide safety-risk register ↗U.S. Food and Drug Administration
- BPOM Cek KLIK ↗Badan POM
- Health effects of ultraviolet radiation ↗World Health Organization
Continue the evidence trail.
Related guides deepen the distinction between mechanism, analytical quality, approval and human evidence.